ABSTRACT
Introduction
The liver lies as the intersection of portal and systemic circulation. As a result, it maintains a tolerogenic environment that dampens responses to highly immunogenic material arriving in intestinal blood. Numerous pathogens, including the HCV and malaria, exploit the immunosuppressive liver microenvironment to establish persistent infections that can lead to the development of hepatocellular carcinoma [1] . Persistence of hepatotropic pathogens is strongly correlated to impaired T cell responses in the liver microenvironment [2] . However, despite our knowledge of cellular and molecular mechanisms contributing to T cell dysfunction in chronic hepatic infections, attempts at developing prophylactic or therapeutic vaccines have failed.
Induction and maintenance of efficient T cell responses are highly dependent on priming by DCs [3] . Immature DCs are activated by broadly conserved pattern recognition receptors (i.e., TLRs), along with proinflammatory cytokines (i.e., IFN-g) [4, 5] . Upon activation/maturation, DCs up-regulate antigenpresenting molecules (i.e., MHC-I and -II) and costimulatory molecules (i.e., CD80 and CD86) necessary for optimal T cell activation [4] . The liver includes diverse DC populations, including conventional tissue-resident CD11b + and CD103 + subsets [6] . During acute viral infection, hepatic CD103 + DCs upregulate expression of costimulatory molecules and preferentially present viral antigen on MHC-I to naïve CD8 + T cells [6] . However, during chronic viral infection, liver-resident DCs may exhibit inefficient activation/maturation, limiting their capacity to generate robust CD8 + T cell responses capable of clearing virus. Recently, ILCs have emerged as important regulators of acute and chronic inflammatory responses and are classified into 3 groups [7] . Of these, group 1 ILCs, which are further divided into T-bet + Eomes 2 CD49a + ILC1s and T-bet + Eomes + CD49b + conventional NK cells, are similar to the CD4 + T H 1 lineage, in that they produce IFN-g upon stimulation [8, 9] . Group 1 ILCs regulate DC function by direct killing of immature DCs via cytolytic molecules (i.e., granzymes, perforin) or conversely, enhancing DC activation via production of cytokines (i.e., IFN-g, TNF-a) [10] . Compared with the spleen, hepatic group 1 ILCs exhibit limited Ly49 receptor expression and reduced capacity to produce IFN-g upon IL-12/IL-18 stimulation [11] . Parabiosis studies have further distinguished the 2 subsets, where CD49a + ILC1s were found to be sessile, perhaps indicating their differentiation from a liver-resident precursor, whereas CD49b + NK cells migrate through blood, suggesting that they are extrahepatically derived, likely from the bone marrow [12, 13] . Initial recruitment of NK cells into the liver during viral infection is dependent on the chemokine CCL3 [14] . This initial influx of NK cells into the infected organ increases local expression of IFN-g, which triggers production of CXCL9 required for more robust, subsequent infiltration of NK cells [15, 16] . This sequence of chemokine production is likely tightly regulated during viral infection. Importantly, recruited IFN-g + CD49b + NK cells have been demonstrated to cross talk with DCs, leading to strong anti-viral T cell responses required for efficient viral clearance [10] . However, the molecular and cellular signals suppressing effective NK-DC crosstalk within the liver's tolerogenic immune environment have yet to be elucidated.
In this study, we sought to determine the regulatory role of CD49a + ILC1s in suppressing hepatic DC activation during infection. Ad is an important human pathogen and has been used as a candidate vaccine against HIV and HCV [17, 18] + T cell responses to pathogens invading the liver and potential pathogens draining the gut. Moreover, these findings implicate that ILC1s are a potential cellular target in designing vaccine strategies and therapeutic venues for chronic bloodborne hepatic viral infections (e.g., HCV).
MATERIALS AND METHODS

Mice
All experiments used 8-to 12-wk-old gender/age-matched male and female mice. Thy1. [19] . These mice were generated on the 129/SJ genetic background and back crossed onto the B6 background by speed congenics using high-density single nucleotide polymorphism chips. Mice were handled according to protocols approved by the University of Virginia Institutional Animal Care and Use Committee.
Virus
Replication-defective recombinant Ad type 5 expressing OVA under the human CMV promoter and lacking E1 and E3 genes was purchased from the Viral Vector Core Facility, University of Iowa (Iowa City, IA, USA). Mice were injected intravenously with 2.5 3 10 7 IU Ad-OVA.
Liver and spleen leukocyte isolation
Livers were perfused with PBS via the portal vein until blanched and then put in IMDM, supplemented with 10% newborn calf serum. Whole livers were passed through a metal spleen screen and digested with 0.05% collagenase IV (Sigma-Aldrich, St. Louis, MO, USA) for 30 min at 37°C. Intrahepatic mononuclear cells were purified on a 21% Histodenz (Sigma-Aldrich) gradient after centrifugation at 1250 g for 20 min without braking. Spleens were passed through a mesh spleen screen, followed by RBC lysis. All samples were resuspended in IMDM plus serum. Leukocytes were counted on a hemocytometer.
Flow cytometry and intracellular staining
Cells were labeled with antibodies against CD45, CD3e, NKp46, NK1.1, CD49a, CD49b, NKG2A-B6, NKG2A/C/E, CD94, T-bet, Eomes, CD69, B220, I-A/I-E, CD11c, CD11b, CD8a, CD103, CD80, CD86, Thy1. In vitro chemotaxis assay NK cells were magnetically isolated from the spleens of naïve B6 and NKG2A 2/2 mice by positive selection for CD49b (Stemcell Technologies, Vancouver, BC, Canada) and assessed for migration. In brief, 2 3 10 5 cells in 100 ml were plated in the upper chamber of a 5 mm Transwell filter in a 24-well plate. The lower chambers contained 600 ml medium containing 0, 10, 20, or 40 ng/ml recombinant CXCL9 (R&D Systems). After 3 h at 37°C, cells were harvested from the lower chamber and stained for FACS analysis.
qRT-PCR analysis
RNA was isolated using the RNeasy mini kit (Qiagen, Valencia, CA, USA) and reverse transcribed using the high-capacity RNA-to-cDNA kit (Thermo Fisher Scientific). QuantiTect primers for qRT-PCR for H2-T23 (Qa-1b) were purchased from Qiagen. Amplification was performed on a StepOnePlus RealTime PCR system and detected by SYBR Green incorporation (Thermo Fisher Scientific).
Adoptive transfer of TCR Tg T cells 
DC and group 1 ILC isolation
Liver DCs and group 1 ILCs were isolated from animals (7-10 B6 or NKG2A 2/2 mice) infected with 2.5 3 10 7 IU Ad-OVA for 12 h before harvest. For DC isolation, CD11c + cells were first enriched by positive selection (Miltenyi Biotec). DCs were stained using antibodies for CD45, MHC-II, CD11c, B220, CD11b, and CD103. Group 1 ILCs were stained using antibodies for CD45, CD3e, NKp46, CD49a, and CD49b. Cells were sorted by flow cytometry using a BD Influx cell sorter at the Flow Cytometry Core Facility (University of Virginia).
In vitro priming of naïve OT-I T cells
FACS-sorted liver DCs, isolated 12 hpi from livers of infected B6 or NKG2A 2/2 mice, were cultured with CFSE-labeled OT-I T cells at a ratio of 1:10 for 4 d at 37°C. All DC:T cell coculture media included IMDM supplemented with 10% heat-inactivated HyClone FBS, 10 U/ml penicillin G/streptomycin, 2 mM L-glutamine, 5 mM 2-ME, 20 mM HEPES, and 100 mg/ml gentamycin (all from Thermo Fisher Scientific).
Statistical analysis
Student's t tests (2-tailed) or 1-way ANOVA with Tukey's post-test were used as appropriate to evaluate the significance of the differences. A value of P , 0.05 was regarded as statistically significant.
RESULTS
CD49a
+ ILC1s are the major liver-resident ILC subset in the steady state and preferentially localize to the perivascular spaces near the portal triads Recent studies describing transcriptional differences between the liver-resident group 1 ILC subsets have helped establish their key defining features; however, there is contrasting data as to the accurate representation of these cells in the steady state [12, 20, 21] . To define a physiologically relevant representation of liverresident group 1 ILCs, we isolated mononuclear cells from murine livers using Histodenz gradient centrifugation following tissue digestion with collagenase IV. When naïve livers are subjected to enzymatic digestion for increasing time intervals, the frequency and cellularity of isolated CD49a + ILC1s increase proportionally to the digestion time (Fig. 1A and B CD11c, CD69, and NKG2A (Fig. 1D) . ILC population starting at 3 hpi, which declined to levels similar to the steady state by 48 hpi (Fig. 2A) ILCs follow a similar pattern of influx and contraction (Fig. 2B) .
We next evaluated surface expression of CD11c, CD69, and NKG2A at 12 hpi on group 1 ILCs (Fig. 2C) (Fig. 2C) . In contrast, expression of Eomes, which is more specific to the NK cell lineage, was more robust in CD49a + CD49b + ILCs and CD49b + NK cells (Fig. 2C) Group 1 ILCs in NKG2A 2/2 livers produce CXCL9 that promotes peripheral NK cell infiltration into the liver NKG2A is a member of the inhibitor NK receptor family. Engagement of the CD94/NKG2A heterodimer transduces a negative signal through the 2 intracytoplasmic ITIMs on NKG2A. 
+ ILC1s express higher levels of NKG2A when compared with CD49b + NK cells (Fig. 2C) Fig. 1A and B) . Although comparable at steady state, the livers of NKG2A 2/2 mice exhibit a greater frequency and cellularity in group 1 ILCs than B6 livers at 12 and 24 hpi (Fig. 3A and B) . Interestingly, only CD49b + NK cells and CD49a + CD49b + ILCs in the NKG2A 2/2 livers exhibit increased cellularity at 12 hpi (Fig. 3C and D) . In contrast, CD49a + ILC1s in both the B6 and NKG2A 2/2 livers display no differences in cellularity at 12 hpi or later time points assessed ( Fig. 3D ; data not shown).
As previously reported, CD49b + NK cells are recruited to the liver during viral infection [16] . To test the possibility that the enhanced number of CD49b + NK cells observed in the NKG2A mice ( Fig. 5A and B) . Although we find no differences in IFN-g protein expression between the B6 and NKG2A 2/2 group 1 ILCs, the cellularity of IFN-g + CD49b + NK cells is increased in NKG2A 2/2 livers at 12 hpi (Fig. 5C ). Of note, we were able to detect IFN-g + CD49a + ILC1s upon IL-12/IL-18 restimulation, although at significantly lower levels than CD49b + NK cells; however, similar to restimulation with NKp46, there were no differences in IFN-g production in any of the subsets between the B6 and NKG2A intravenous Ad-OVA infection and analyzed the livers at 3 dpi for both the accumulation of OT-I T cells and their CFSE dilution profiles. Infected NKG2A 2/2 T cell recipients displayed increased frequency and total numbers of responding OT-I T cells in the livers at 3 dpi ( Fig. 6A and C) . Moreover, the CFSE dilution profile of OT-I T cells in B6 and NKG2A 2/2 recipients revealed a more rapid division in the NKG2A 2/2 livers (Fig. 6A) .
In addition to an accelerated rate of proliferation, activated (responding) OT-I T cells isolated from the livers of NKG2A 2/2 mice at 3 dpi are able to secrete more IFN-g, as measured by both frequency and MFI upon in vitro stimulation with cognate antigen (Fig. 6B and D) . The enhanced cellularity and effector function seen in OT-I T cells in the NKG2A 2/2 livers are likely a result of greater activation/maturation of hepatic DCs in these mice. Indeed, despite modest differences in frequencies between B6 and NKG2A 2/2 livers, the cellularity of total, CD11b + , and CD103 + DCs are increased in NKG2A 2/2 livers at 0, 12, and 24 hpi compared with those from B6 mice (Supplemental Fig. 2A-C) . This increase was not a result of intrinsic influence of NKG2A signaling on liver-resident DCs, as cells that did not express NK1.1, including hepatic DCs, lacked surface expression of NKG2A (data not shown). Interestingly, the expression of the Qa-1 b transcript, the IFN-g-inducible ligand for NKG2A, is enhanced in sorted CD11b + and CD103 + DCs from the NKG2A 2/2 livers at 12 hpi; nonetheless, CD11b + and CD103 + DCs transcribe Qa-1 b to similar levels in both B6 and NKG2A 2/2 livers (Supplemental Fig. 2D) . Thus, the global increase in IFN-g production by infiltrating CD49b + NK cells is likely mediating proinflammatory signaling events on multiple local immune cells.
We also evaluated the maturation status of CD11b + and CD103 + DCs via expression of the costimulatory receptors CD80 and CD86. Although equal in the naïve livers, both the CD11b + and CD103 + DCs in the NKG2A 2/2 express higher levels of CD86 when compared with the corresponding DC subsets from B6 mice at 12 and 24 hpi (Supplemental Fig. 2E and F) . In contrast, although the CD103 + DCs express enhanced CD80 expression in the NKG2A 2/2 livers at 12 hpi, as measured by MFI, the CD11b + DC subset exhibits no differences between the B6 and NKG2A 2/2 mice (Supplemental Fig. 2F ). This transient up-regulation of costimulatory receptors was reduced upon administration of anti-CXCL9 antibody (Supplemental Fig. 3 ), underscoring the importance of NK cells in recruiting and activating DC subsets in hepatic viral infection. 7A) . This enhanced stimulatory capacity of NKG2A 2/2 CD103 + DCs was also evident from the elevated numbers of total OT-I CD8 + T cells recovered at the end of the in vitro coculture (Fig. 7B) . In contrast to the differences in OT-I CD8 + T cell number seen with the CD103 + DC subsets, the CD11b + DCs from both the B6 and NKG2A 2/2 livers supported similar low-level accumulation in OT-I CD8 + T cells ( Fig. 7A and B (Fig. 2B) .
Despite constant cellularity of CD49a + ILC1s, they may play a critical role in orchestrating the infiltration of CD49b + NK cells. When compared with CD49b + NK cells, liver-resident group 1 ILCs from NKG2A 2/2 mice expressed higher levels of the IFNg-inducible NK cell chemoattractant CXCL9 at 12 hpi (Fig. 4A) . Indeed, cell division in response to IL-15 and staining for the proliferation marker Ki67 in NK cells exhibited no differences between the B6 and NKG2A 2/2 mice, suggesting that enhanced CD49b + NK cellularity is solely a result of increased recruitment in NKG2A 2/2 livers (Supplemental Fig. 4 ). NKG2A signaling, via recruitment of the phosphatases SH2 domain-containing phosphatase 1 and 2/SH2 domain-containing inositol 59-phosphatase, may limit phosphorylated Jak1-or STAT1-mediated production of CXCL9 in group 1 ILCs, especially in CD49a + ILC1s, which express high levels of NKG2A [23] . In addition, NKG2A 2/2 mice retain some (,2%) founding 129 alleles as a result of high-linkage disequilibrium in the NK complex. Consequently, the enhanced chemokine expression during infection in NKG2A 2/2 group 1 ILCs may stem from NKG2A and additional signaling events. IFN-g is used by DCs and macrophages for their activation and survival [24] [25] [26] [27] . Moreover, expression of Qa-1 b , a nonclassic MHC that serves as the ligand for NKG2A, is induced upon IFN-g signaling [28] [29] . Thus, NKG2A signaling on hepatic ILC1s reins in local IFN-g production, preventing liverresident DCs from reaching the threshold of activation necessary for initiating a robust immune response.
At present, there is an urgent need for vaccines capable of inducing robust and sustainable CD8 + T cell responses to chronic or persistent hepatic infections. It has previously been shown that NKG2A signaling in activated CD8 + T cells suppresses their effector functions, suggesting that global blockade of NKG2A may be beneficial in generating robust anti-viral CD8 + T cell responses [19] . In this report, we examine the role of NKG2A on innate hematopoietic cells, while excluding the role of NKG2A on activated CD8 + T cells. We demonstrate NKG2A-competent OT-I T cell accumulation, with significantly higher levels of IFN-g in the NKG2A 2/2 livers at 3 dpi (Fig. 6A-D [31] . Furthermore, the absence of NKG2A expression on group 1 ILCs is associated with increased resistance to HCV infection [32] . Therefore, the blocking of NKG2A on group 1 ILCs-in particular, CD49a 
